{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:51:19Z","timestamp":1769640679130,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,9]]},"DOI":"10.7759\/cureus.27806","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:04:51Z","timestamp":1660043091000},"source":"Crossref","is-referenced-by-count":1,"title":["Catecholaminergic Polymorphic Ventricular Tachycardia Presented As Generalized Tonic-Clonic Seizure: A Case Report"],"prefix":"10.7759","author":[{"given":"Shraddha","family":"Acharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratichhya","family":"Devkota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashik K","family":"Bajracharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Jesmajian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt A","year":"1995","unstructured":"Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation. 1995, 91:1512-9. 10.1161\/01.cir.91.5.1512","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00092","article-title":"CPVT: arrhythmogenesis, therapeutic management, and future perspectives. A brief review of the literature","volume":"6","author":"Baltogiannis GG","year":"2019","unstructured":"Baltogiannis GG, Lysitsas DN, di Giovanni G, et al.. CPVT: arrhythmogenesis, therapeutic management, and future perspectives. A brief review of the literature. Front Cardiovasc Med. 2019, 6:92. 10.3389\/fcvm.2019.00092","journal-title":"Front Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi M","year":"2009","unstructured":"Hayashi M, Denjoy I, Extramiana F, et al.. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation. 2009, 119:2426-34. 10.1161\/CIRCULATIONAHA.108.829267","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000020013.73106.d8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori SG","year":"2002","unstructured":"Priori SG, Napolitano C, Memmi M, et al.. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002, 106:69-74. 10.1161\/01.cir.0000020013.73106.d8","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.74.2.340","article-title":"Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval","volume":"74","author":"Nguyen PT","year":"1986","unstructured":"Nguyen PT, Scheinman MM, Seger J. Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval. Circulation. 1986, 74:340-9. 10.1161\/01.cir.74.2.340","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.63.3.169","article-title":"Familial ventricular tachycardia: a report of four families","volume":"63","author":"Wren C","year":"1990","unstructured":"Wren C, Rowland E, Burn J, Campbell RW. Familial ventricular tachycardia: a report of four families. Br Heart J. 1990, 63:169-74. 10.1136\/hrt.63.3.169","journal-title":"Br Heart J"},{"key":"ref7","article-title":"Catecholaminergic polymorphic ventricular tachycardia","author":"Napolitano C","year":"2022","unstructured":"Napolitano C, Mazzanti A, Bloise R, et al..  Catecholaminergic polymorphic ventricular tachycardia. GeneReviews\u00ae [Internet]. University of Washington, Seattle (WA); 2022."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori SG","year":"2001","unstructured":"Priori SG, Napolitano C, Tiso N, et al.. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001, 103:196-200. 10.1161\/01.cir.103.2.196","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab687","article-title":"Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death","volume":"43","author":"Walsh R","year":"2022","unstructured":"Walsh R, Adler A, Amin AS, et al.. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death. Eur Heart J. 2022, 43:1500-10. 10.1093\/eurheartj\/ehab687","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.37.3.339","article-title":"Bidirectional tachycardia in a child. A study using His bundle electrography","volume":"37","author":"Reid DS","year":"1975","unstructured":"Reid DS, Tynan M, Braidwood L, Fitzgerald GR. Bidirectional tachycardia in a child. A study using His bundle electrography. Br Heart J. 1975, 37:339-44. 10.1136\/hrt.37.3.339","journal-title":"Br Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2008.050534","article-title":"Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation","volume":"43","author":"Campbell RM","year":"2009","unstructured":"Campbell RM, Berger S, Drezner J. Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation. Br J Sports Med. 2009, 43:336-41. 10.1136\/bjsm.2008.050534","journal-title":"Br J Sports Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.629610","article-title":"RYR2 mutations are associated with benign epilepsy of childhood with centrotemporal spikes with or without arrhythmia","volume":"15","author":"Ma MG","year":"2021","unstructured":"Ma MG, Liu XR, Wu Y, et al.. RYR2 mutations are associated with benign epilepsy of childhood with centrotemporal spikes with or without arrhythmia. Front Neurosci. 2021, 15:629610. 10.3389\/fnins.2021.629610","journal-title":"Front Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4065\/79.11.1380","article-title":"Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner\/coroner's cases","volume":"79","author":"Tester DJ","year":"2004","unstructured":"Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner\/coroner's cases. Mayo Clin Proc. 2004, 79:1380-4. 10.4065\/79.11.1380","journal-title":"Mayo Clin Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2019.05.006","article-title":"Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT)","volume":"62","author":"Singh M","year":"2019","unstructured":"Singh M, Morin DP, Link MS. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). Prog Cardiovasc Dis. 2019, 62:227-34. 10.1016\/j.pcad.2019.05.006","journal-title":"Prog Cardiovasc Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(99)00438-6","article-title":"Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing","volume":"34","author":"Fisher JD","year":"1999","unstructured":"Fisher JD, Krikler D, Hallidie-Smith KA. Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing. J Am Coll Cardiol. 1999, 34:2015-22. 10.1016\/s0735-1097(99)00438-6","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf C","year":"2011","unstructured":"van der Werf C, Kannankeril PJ, Sacher F, et al.. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol. 2011, 57:2244-54. 10.1016\/j.jacc.2011.01.026","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2005.40516.x","article-title":"Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations","volume":"16","author":"Swan H","year":"2005","unstructured":"Swan H, Laitinen P, Kontula K, Toivonen L. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol. 2005, 16:162-6. 10.1046\/j.1540-8167.2005.40516.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.028993","article-title":"Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients","volume":"42","author":"Postma AV","year":"2005","unstructured":"Postma AV, Denjoy I, Kamblock J, et al.. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet. 2005, 42:863-70. 10.1136\/jmg.2004.028993","journal-title":"J Med Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107947-catecholaminergic-polymorphic-ventricular-tachycardia-presented-as-generalized-tonic-clonic-seizure-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:08Z","timestamp":1707507428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107947-catecholaminergic-polymorphic-ventricular-tachycardia-presented-as-generalized-tonic-clonic-seizure-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.27806","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}